Adelborg, K., Horvath-Puho, E., Ording, A., Pedersen, L., Toft Sorensen, H. and Henderson, V. W. (2017). Heart failure and risk of dementia: a Danish nationwide population-based cohort study. European Journal of Heart Failure, 19, 253–260.
Andersson, T., Alfredsson, L., Kallberg, H., Zdravkovic, S. and Ahlbom, A. (2005). Calculating measures of biological interaction. European Journal of Epidemiology, 20, 575–579.
Azarpazhooh, M.R., Avan, A., Cipriano, L.E., Munoz, D.G., Sposato, L.A. and Hachinski, V. (2018). Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimer’s & Dementia, 14, 148–156.10.1016/j.jalz.2017.07.755
Baumgart, M., Snyder, H.M., Carrillo, M.C., Fazio, S., Kim, H. and Johns, H. (2015). Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimer’s & Dementia, 11, 718–726.
Benjamini, Y. and Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Methodological), 57, 289–300.
Berkowitz, C.L., Mosconi, L., Rahman, A., Scheyer, O., Hristov, H. and Isaacson, R.S. (2018). Clinical Application of APOE in Alzheimer’s Prevention: A Precision Medicine Approach. The Journal of Prevention of Alzheimer’s Disease, 5, 245–252.
Choi, B.R. et al. (2006). Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. The American Journal of Cardiology, 97, 1365–1369.
de Frias, C.M., Schaie, K.W. and Willis, S.L. (2014). Hypertension moderates the effect of APOE on 21-year cognitive trajectories. Psychology and Aging, 29, 431–439.
de Leeuw, F.E., et al. (2004). Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke, 35, 1057–1060.
Diniz, B.S., Butters, M.A., Albert, S.M., Dew, M.A. and Reynolds, C.F. (2013). Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. British Journal of Psychiatry, 202, 329–335.
Erickson, K.I., Miller, D.L. and Roecklein, K.A. (2012). The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist, 18, 82–97.
Erickson, K.I. et al. (2010). Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology, 75, 1415–1422.
Etnier, J.L. et al. (2007). Cognitive performance in older women relative to ApoE-epsilon4 genotype and aerobic fitness. Medicine & Science in Sports & Exercise, 39, 199–207.
Ferguson, T.W., Komenda, P. and Tangri, N. (2015). Cystatin C as a biomarker for estimating glomerular filtration rate. Current Opinion in Nephrology and Hypertension, 24, 295–300.
Folstein, M.F., Folstein, S.E. and McHugh, P.R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.10.1016/0022-3956(75)90026-6
Ganguli, M., Gilby, J., Seaberg, E. and Belle, S. (1995). Depressive Symptoms and Associated Factors in a Rural Elderly Population: The MoVIES Project. The American Journal of Geriatric Psychiatry, 3, 144–160.
Huang, Y. (2010). Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer’s disease. Trends in Molecular Medicine, 16, 287–294.
Hughes, T.F., Becker, J.T., Lee, C.W., Chang, C.C. and Ganguli, M. (2015). Independent and combined effects of cognitive and physical activity on incident MCI. Alzheimer’s & Dementia, 11, 1377–1384.
Intlekofer, K.A. and Cotman, C.W. (2013). Exercise counteracts declining hippocampal function in aging and Alzheimer’s disease. Neurobiology of Disease, 57, 47–55.
Ivan, C.S. et al. (2004). Dementia after stroke: the Framingham Study. Stroke, 35, 1264–1268.
Jin, Y.P., Di Legge, S., Ostbye, T., Feightner, J.W. and Hachinski, V. (2006). The reciprocal risks of stroke and cognitive impairment in an elderly population. Alzheimer’s & Dementia, 2, 171–178.
Jin, Y.P., Ostbye, T., Feightner, J.W., Di Legge, S. and Hachinski, V. (2008). Joint effect of stroke and APOE 4 on dementia risk: the Canadian Study of Health and Aging. Neurology, 70, 9–16.
Jorgensen, D.R., Shaaban, C.E., Wiley, C.A., Gianaros, P.J., Mettenburg, J. and Rosano, C. (2018). A population neuroscience approach to the study of cerebral small vessel disease in mid- and late-life: an Invited Review. American Journal of Physiology-Heart and Circulatory Physiology.
Kivipelto, M. et al. (2008). Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study. Journal of Cellular and Molecular Medicine, 12, 2762–2771.
Klein, J.P. and Moeschberger, M.L. (2003). Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer.
Kloppenborg, R.P., Nederkoorn, P.J., Geerlings, M.I. and van den Berg, E. (2014). Presence and progression of white matter hyperintensities and cognition: a meta-analysis. Neurology, 82, 2127–2138.
Kokmen, E., Whisnant, J.P., O’Fallon, W.M., Chu, C.P. and Beard, C.M. (1996). Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology, 46, 154–159.
Llewellyn, D.J. et al. (2010). Vascular health, diabetes, APOE and dementia: the Aging, Demographics, and Memory Study. Alzheimer’s Research & Therapy, 2, 19.
Morris, J.C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412–2414.
Pantoni, L., Fierini, F. and Poggesi, A. (2015). Impact of cerebral white matter changes on functionality in older adults: an overview of the LADIS Study results and future directions. Geriatrics & Gerontology International, 15 Suppl 1, 10–16.
Peila, R. et al. (2001). Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study. Stroke, 32, 2882–2889.
Perales, J., Hinton, L., Burns, J. and Vidoni, E.D. (2018). Cardiovascular health and cognitive function among Mexican older adults: cross-sectional results from the WHO Study on Global Ageing and Adult Health. International Psychogeriatrics, 30, 1827–1836.
Piercy, K.L. et al. (2018). The Physical Activity Guidelines for Americans. JAMA, 320, 2020–2028.
Prins, N.D. et al. (2004). Cerebral white matter lesions and the risk of dementia. Archives of Neurology, 61, 1531–1534.
Qiu, C., Winblad, B., Marengoni, A., Klarin, I., Fastbom, J. and Fratiglioni, L. (2006). Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Archives of Internal Medicine, 166, 1003–1008.
R Core Team. (2018). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
Reitz, C., Bos, M.J., Hofman, A., Koudstaal, P.J. and Breteler, M.M. (2008). Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. Stroke, 39, 36–41.
Rosano, C. et al. (2017). Hippocampal response to a 24-month physical activity intervention in sedentary older adults. The American Journal of Geriatric Psychiatry, 25, 209–217.
Roy, B., Woo, M.A., Wang, D.J.J., Fonarow, G.C., Harper, R.M. and Kumar, R. (2017). Reduced regional cerebral blood flow in patients with heart failure. European Journal of Heart Failure, 19, 1294–1302.
Rusanen, M. et al. (2014). Heart diseases and long-term risk of dementia and Alzheimer’s disease: a population-based CAIDE study. Journal of Alzheimer’s Disease, 42, 183–191.
Salive, M.E. (2013). Multimorbidity in older adults. Epidemiologic Reviews, 35, 75–83.
SAS Inst. (2013). The SAS system for Windows. Cary, NC: SAS Institute.
Snyder, H.M. et al. (2015). Vascular contributions to cognitive impairment and dementia including Alzheimer’s disease. Alzheimer’s & Dementia, 11, 710–717.
van Dijk, E.J. et al. (2005). C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation, 112, 900–905.
Vemuri, P. et al. (2017). Age, vascular health, and Alzheimer disease biomarkers in an elderly sample. Annals of Neurology, 82, 706–718.
Vermeer, S.E. et al. (2002). Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Annals of Neurology, 51, 285–289.
Wagner, M., Helmer, C., Tzourio, C., Berr, C., Proust-Lima, C. and Samieri, C. (2018). Evaluation of the concurrent trajectories of cardiometabolic risk factors in the 14 years before dementia. JAMA Psychiatry, 75, 1033–1042.
Walker, K.A., Power, M.C. and Gottesman, R.F. (2017). Defining the relationship between hypertension, cognitive decline, and dementia: a review. Current Hypertension Reports, 19, 24.
Walldius, G. and Jungner, I. (2006). The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence. Journal of Internal Medicine, 259, 493–519.
Wong, A., Mok, V., Fan, Y.H., Lam, W.W., Liang, K.S. and Wong, K.S. (2006). Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease. Journal of Neurology, 253, 441–447.
Yuan, M. et al. (2018). Associations between modifiable lifestyle factors and multidimensional cognitive health among community-dwelling old adults: stratified by educational level. International Psychogeriatrics, 30, 1465–1476.
Zhu, L. et al. (2000). Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study. Stroke, 31, 53–60.